These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 9668534

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Hydroxyurea and other agents stimulating synthesis of fetal hemoglobin].
    de Montalembert M.
    Pathol Biol (Paris); 1999 Jan; 47(1):55-8. PubMed ID: 10081780
    [Abstract] [Full Text] [Related]

  • 27. Combination therapy of erythropoietin, hydroxyurea, and clotrimazole in a beta thalassemic mouse: a model for human therapy.
    de Franceschi L, Rouyer-Fessard P, Alper SL, Jouault H, Brugnara C, Beuzard Y.
    Blood; 1996 Feb 01; 87(3):1188-95. PubMed ID: 8562946
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cerebrovascular events in sickle cell-beta thalassemia treated with hydroxyurea: a single center prospective survey in adult Italians.
    Rigano P, Pecoraro A, Calvaruso G, Steinberg MH, Iannello S, Maggio A.
    Am J Hematol; 2013 Nov 01; 88(11):E261-4. PubMed ID: 23828131
    [Abstract] [Full Text] [Related]

  • 31. CNTO 530 increases expression of HbA and HbF in murine models of β-thalassemia and sickle cell anemia.
    Makropoulos DA, Achuthanandam R, Avery J, Wilson K, Brosnan K, Miller A, Nesspor T, Chroscinski D, Walker M, Egenolf D, Huang C, Bugelski PJ.
    Curr Pharm Biotechnol; 2013 Nov 01; 14(2):242-8. PubMed ID: 23157711
    [Abstract] [Full Text] [Related]

  • 32. Pharmacological induction of fetal hemoglobin in sickle cell disease and beta-thalassemia.
    Atweh GF, Loukopoulos D.
    Semin Hematol; 2001 Oct 01; 38(4):367-73. PubMed ID: 11605172
    [Abstract] [Full Text] [Related]

  • 33. Sickle cell pain crisis.
    Davies SC, Bevan DH.
    Lancet; 1996 Jan 27; 347(8996):263. PubMed ID: 8551907
    [No Abstract] [Full Text] [Related]

  • 34. Quantification of HBG mRNA in primary erythroid cultures: prediction of the response to hydroxyurea in sickle cell and beta-thalassemia.
    Pecoraro A, Rigano P, Troia A, Calzolari R, Scazzone C, Maggio A, Steinberg MH, Di Marzo R.
    Eur J Haematol; 2014 Jan 27; 92(1):66-72. PubMed ID: 24112139
    [Abstract] [Full Text] [Related]

  • 35. Pharmacologic manipulation of fetal hemoglobin. Update on clinical trials with hydroxyurea.
    Dover GJ.
    Ann N Y Acad Sci; 1990 Jan 27; 612():184-90. PubMed ID: 1705407
    [No Abstract] [Full Text] [Related]

  • 36. Effect of hydroxyurea on G gamma chain fetal hemoglobin synthesis by sickle-cell disease patients.
    Teixeira SM, Cortellazzi LC, Grotto HZ.
    Braz J Med Biol Res; 2003 Oct 27; 36(10):1289-92. PubMed ID: 14502358
    [Abstract] [Full Text] [Related]

  • 37. Hydroxyurea increases fetal hemoglobin in cultured erythroid cells derived from normal individuals and patients with sickle cell anemia or beta-thalassemia.
    Fibach E, Burke LP, Schechter AN, Noguchi CT, Rodgers GP.
    Blood; 1993 Mar 15; 81(6):1630-5. PubMed ID: 7680923
    [Abstract] [Full Text] [Related]

  • 38. Hydroxyurea for sickle cell anemia.
    Naina HV, Harris S.
    N Engl J Med; 2008 Jul 03; 359(1):98; author reply 98-9. PubMed ID: 18596283
    [No Abstract] [Full Text] [Related]

  • 39. Relationship of erythropoietin, fetal hemoglobin, and hydroxyurea treatment to tricuspid regurgitation velocity in children with sickle cell disease.
    Gordeuk VR, Campbell A, Rana S, Nouraie M, Niu X, Minniti CP, Sable C, Darbari D, Dham N, Onyekwere O, Ammosova T, Nekhai S, Kato GJ, Gladwin MT, Castro OL.
    Blood; 2009 Nov 19; 114(21):4639-44. PubMed ID: 19724057
    [Abstract] [Full Text] [Related]

  • 40. Exposure to hydroxyurea during pregnancy in sickle-beta thalassemia: a report of 2 cases.
    Italia KY, Jijina FF, Chandrakala S, Nadkarni AH, Sawant P, Ghosh K, Colah RB.
    J Clin Pharmacol; 2010 Feb 19; 50(2):231-4. PubMed ID: 19797538
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.